Yahoo! Finance: Dialectic Therapeutics announces first-in-human dose in Phase 1 clinical trial evaluating DT2216
October 6, 2021
Renowned cancer centers participating in the trial include the Mays Cancer Center at UT Health San Antonio, Mary Crowley Cancer Research in Dallas, Texas and The Lurie Cancer Center at Northwestern University in Chicago, Illinois. Based in Dallas, Texas, Dialectic has research partners and facilities at UT Health San Antonio and University of Florida Health. […]
